News | Breast Density | October 21, 2019

Partnership will provide access to artificial intelligence-powered breast density assessment to Nuance’s nationwide network of radiologists

Densitas Breast Density Assessment Software Joins Nuance AI Marketplace

October 21, 2019 — Densitas Inc. announced that its U.S. Food and Drug Administration (FDA)-cleared densitas densityai breast density assessment software will be available on the Nuance AI Marketplace. The company said the marketplace provides access to more than 70 percent of all radiologists across the largest network of connected healthcare facilities in the U.S.

Densitas densityai delivers fully automated, standardized and reproducible breast density assessments from standard DICOM (Digital Imaging and Communications in Medicine) clinical use images. Density assessments can be incorporated into risk models that evaluate patient-specific breast cancer risk. The artificial intelligence (AI)-powered densitas densityai solution is specifically designed to align with how the visual cortex processes breast images when radiologists visualize mammograms, and rapidly generates reproducible and standardized breast density assessments that line up with the American College of Radiology (ACR) Breast Imaging-Reporting and Data System) BI-RADS 5th ed. Atlas guidance on interpreting breast density from clinical use mammograms. Densitas recently announced that densitas densityai has been selected for use in a major breast screening trial in Germany.

"AI can play an important supporting role for radiologists by automating routine, time-consuming, subjective and fatiguing tasks so that they can focus on more challenging interpretive tasks," said Woojin Kim, M.D., chief medical information officer at the Healthcare Division of Nuance Communications. "What sets densitas densityai apart is that it has been thoughtfully designed to process routinely archived mammograms so that breast density assessments can be obtained from historical studies when comparing current with prior exams.  What I find compelling is that the density results are deeply embedded in the reporting workflow to deliver important information to radiologists at the time of interpretation while automatically populating the report."

Watch the VIDEO: The Role of Analytics in Value-Based Healthcare, an interview with Kim

Listen to the PODCAST: Why Blockchain Matters In Medical Imaging, an interview with Kim

For more information: www.densitas.health, www.nuance.com


Related Content

News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Feature | Information Technology | Kyle Hardner

Artificial intelligence (AI) has enhanced diagnostic accuracy and improved triage in radiology. But far fewer tools ...

Time July 16, 2026
arrow
News | X-Ray

July 14, 2026 — A team of crew members aboard a commercial spaceflight acquired the first diagnostic X-rays during an ...

Time July 14, 2026
arrow
News | Ultrasound Imaging

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound ...

Time July 09, 2026
arrow
News | Prostate Cancer

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the ...

Time July 08, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Women's Health

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age ...

Time July 01, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
Subscribe Now